rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
23
|
pubmed:dateCreated |
2010-6-10
|
pubmed:abstractText |
A discrete population of splenocytes with attributes of dendritic cells (DCs) and coexpressing the B-cell marker CD19 is uniquely competent to express the T-cell regulatory enzyme indoleamine 2,3-dioxygenase (IDO) in mice treated with TLR9 ligands (CpGs). Here we show that IDO-competent cells express the B-lineage commitment factor Pax5 and surface immunoglobulins. CD19 ablation abrogated IDO-dependent T-cell suppression by DCs, even though cells with phenotypic attributes matching IDO-competent cells developed normally and expressed IDO in response to interferon gamma. Consequently, DCs and regulatory T cells (Tregs) did not acquire T-cell regulatory functions after TLR9 ligation, providing an alternative perspective on the known T-cell regulatory defects of CD19-deficient mice. DCs from B-cell-deficient mice expressed IDO and mediated T-cell suppression after TLR9 ligation, indicating that B-cell attributes were not essential for B-lymphoid IDO-competent cells to regulate T cells. Thus, IDO-competent cells constitute a distinctive B-lymphoid cell type with quintessential T-cell regulatory attributes and phenotypic features of both B cells and DCs.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD19,
http://linkedlifedata.com/resource/pubmed/chemical/B-Cell-Specific Activator Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Indoleamine-Pyrrole 2,3,-Dioxygenase,
http://linkedlifedata.com/resource/pubmed/chemical/Pax5 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Tlr9 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Toll-Like Receptor 9
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1091-6490
|
pubmed:author |
pubmed-author:BusslingerMeinradM,
pubmed-author:ChandlerPhillip RPR,
pubmed-author:JohnsonBurles ABA3rd,
pubmed-author:KahlerDavid JDJ,
pubmed-author:KangBaolinB,
pubmed-author:KoniPandelakis APA,
pubmed-author:MellorAndrew LAL,
pubmed-author:MunnDavid HDH,
pubmed-author:NSS,
pubmed-author:PihkalaJeaneneJ,
pubmed-author:ShimodaMichikoM,
pubmed-author:VilagosBojanB
|
pubmed:issnType |
Electronic
|
pubmed:day |
8
|
pubmed:volume |
107
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
10644-8
|
pubmed:dateRevised |
2011-4-15
|
pubmed:meshHeading |
pubmed-meshheading:20498068-Animals,
pubmed-meshheading:20498068-Antigens, CD19,
pubmed-meshheading:20498068-B-Cell-Specific Activator Protein,
pubmed-meshheading:20498068-B-Lymphocytes,
pubmed-meshheading:20498068-Cell Lineage,
pubmed-meshheading:20498068-Dendritic Cells,
pubmed-meshheading:20498068-Indoleamine-Pyrrole 2,3,-Dioxygenase,
pubmed-meshheading:20498068-Mice,
pubmed-meshheading:20498068-Mice, Knockout,
pubmed-meshheading:20498068-Spleen,
pubmed-meshheading:20498068-T-Lymphocytes,
pubmed-meshheading:20498068-Toll-Like Receptor 9
|
pubmed:year |
2010
|
pubmed:articleTitle |
B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase.
|
pubmed:affiliation |
Immunotherapy and Cancer Centers, Departments of Pathology and Medicine, and Flow Cytometry Core Facility, Medical College of Georgia, Augusta, GA 30912, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|